We may know McLaren for their exotic sports cars and race cars, but company founder and CEO Ron Dennis recently told the Wall Street Journal that McLaren is looking to expand its $1.5 billion company into other fields – including drugs (the legal kind of course).
As a technology company “first and foremost”, McLaren is looking to “applying the technological savvy evident in decades of Formula One podium finishes to fields like pharmaceuticals and transport management.” And it looks like companies are already interested and are using McLaren’s services.
GlaxoSmithKline is looking into McLaren’s Mission Control center, what McLaren uses to monitor all their F1 races. GlaxoSmithKline believes that McLaren could assist in developing a similar control center for data modeling and high-speed process control.
Currently the United Kingdom’s National Air Traffic Services and California’s rail system utilizes McLaren’s telemetry and predictive ability. Ultimately though, McLaren wants to offer custom solutions in various fields including electronics, pneumatics, kinematics, fluid dynamics, material sciences and to implement their telemetry systems to monitor hospital patients in real time.
Us? Well, we just want to see what McLaren’s second vehicle is going to be in their new lineup.
[Source: Inside Line]